Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail

Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail

Source: 
BioPharma Dive
snippet: 

The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’ concerns about the acquisition.